全文获取类型
收费全文 | 1300篇 |
免费 | 201篇 |
国内免费 | 28篇 |
出版年
2024年 | 3篇 |
2023年 | 47篇 |
2022年 | 29篇 |
2021年 | 45篇 |
2020年 | 76篇 |
2019年 | 120篇 |
2018年 | 76篇 |
2017年 | 54篇 |
2016年 | 65篇 |
2015年 | 70篇 |
2014年 | 118篇 |
2013年 | 141篇 |
2012年 | 72篇 |
2011年 | 85篇 |
2010年 | 60篇 |
2009年 | 54篇 |
2008年 | 46篇 |
2007年 | 34篇 |
2006年 | 33篇 |
2005年 | 23篇 |
2004年 | 30篇 |
2003年 | 13篇 |
2002年 | 29篇 |
2001年 | 22篇 |
2000年 | 13篇 |
1999年 | 17篇 |
1998年 | 16篇 |
1997年 | 12篇 |
1996年 | 11篇 |
1995年 | 8篇 |
1994年 | 18篇 |
1993年 | 19篇 |
1992年 | 9篇 |
1991年 | 8篇 |
1990年 | 5篇 |
1989年 | 8篇 |
1988年 | 7篇 |
1987年 | 6篇 |
1986年 | 1篇 |
1985年 | 5篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1982年 | 4篇 |
1981年 | 5篇 |
1980年 | 2篇 |
1979年 | 5篇 |
1976年 | 1篇 |
排序方式: 共有1529条查询结果,搜索用时 15 毫秒
81.
《Bioorganic & medicinal chemistry》2016,24(11):2433-2440
Microtubules are considered as important targets of anticancer therapy. EAPB0503 and its structural imidazo[1,2-a]quinoxaline derivatives are major microtubule-interfering agents with potent anticancer activity. In this study, the synthesis of several new derivatives of EAPB0503 is described, and the anticancer efficacy of 13 novel derivatives on A375 human melanoma cell line is reported. All new compounds show significant antiproliferative activity with IC50 in the range of 0.077–122 μM against human melanoma cell line (A375). Direct inhibition of tubulin polymerization assay in vitro is also assessed. Results show that compounds 6b, 6e, 6g, and EAPB0503 highly inhibit tubulin polymerization with percentages of inhibition of 99%, 98%, 90%, and 84% respectively. Structure–activity relationship studies within the series are also discussed in line with molecular docking studies into the colchicine-binding site of tubulin. 相似文献
82.
目的:探讨右美托咪定对老年恶性肿瘤全麻手术患者术后细胞免疫功能、认知功能及炎症因子水平的影响。方法:选取2017年2月~2019年6月期间到我院择期行手术治疗的老年恶性肿瘤患者119例,根据随机数字表法将患者分为对照组(n=59)和研究组(n=60),研究组麻醉中输注右美托咪定,对照组麻醉中输注同容量等速率的生理盐水,比较两组患者围术期指标、细胞免疫功能、不良反应、炎症因子指标、简易智力状态量表(MMSE)评分。结果:两组患者术后第3 d的CD4~+/CD8~+、CD3~+、CD4~+较术前下降,CD8~+较术前升高(P0.05);研究组术后第3 d的CD4~+/CD8~+、CD3~+、CD4~+高于对照组,CD8~+则低于对照组(P0.05)。两组术后第3 d的血清高迁移率族蛋白1(HMGBl)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平均升高,但研究组低于对照组(P0.05)。两组手术时间、术中出血量、麻醉时间比较无差异(P0.05)。两组患者术前、术后第1 d、术后第3 d的MMSE评分呈先下降后升高趋势(P0.05),且研究组术后第1 d、第3 d的MMSE评分高于对照组(P0.05)。两组不良反应发生率比较无统计学差异(P0.05)。结论:老年恶性肿瘤全麻手术患者术中输注右美托咪定,可减轻细胞免疫抑制及炎症反应,对术后早期的认知功能下降有一定预防作用。 相似文献
83.
84.
85.
Xinshu Xie Saisai Xie Changying Xie Yuanying Fang Zhifeng Li Rikang Wang Wei Jiang 《Journal of cellular and molecular medicine》2019,23(11):7545-7553
Uveal melanoma (UM) has a high mortality rate due to liver metastasis. The insulin‐like growth factor‐1 receptor (IGF‐1R) is highly expressed in UM and has been shown to be associated with hepatic metastases. Targeting IGF signalling may be considered as a promising approach to inhibit the process of metastatic UM cells. Pristimerin (PRI) has been demonstrated to inhibit the growth of several cancer cells, but its role and underlying mechanisms in the IGF‐1‐induced UM cell proliferation are largely unknown. The present study examined the anti‐proliferative effect of PRI on UM cells and its possible role in IGF‐1R signalling transduction. MTT and clonogenic assays were used to determine the role of PRI in the proliferation of UM cells. Flow cytometry was performed to detect the effect of PRI on the cell cycle distribution of UM cells. Western blotting was carried out to assess the effects of PRI and IGF‐1 on the IGF‐1R phosphorylation and its downstream targets. The results indicated that IGF‐1 promoted the UM cell proliferation and improved the level of IGF‐1R phosphorylation, whereas PRI attenuated the effect of IGF‐1. Interestingly, PRI could not only induce the G1 phase accumulation and reduce the G2 phase induced by IGF‐1, but also could stimulate the expression of p21 and inhibit the expression of cyclin D1. Besides, PRI could attenuate the phosphorylations of Akt, mTOR and ERK1/2 induced by IGF‐1. Furthermore, the molecular docking study also demonstrated that PRI had potential inhibitory effects on IGF‐1R. Taken together, these results indicated that PRI could inhibit the proliferation of UM cells through down‐regulation of phosphorylated IGF‐1R and its downstream signalling. 相似文献
86.
目的: 探讨恶性血液病外周血淋巴细胞亚群变化特征及临床意义。方法: 采用流式细胞仪检测64例初诊的血液系统恶性肿瘤患者的外周血淋巴细胞亚群。病种包括急性髓系白血病(acute myeloid leukemia,AML)、急性淋巴细胞白血病(acute lymphoblastic leukemia,ALL)、霍奇金淋巴瘤(Hodgkin’s lymphoma,HL)、非霍奇金淋巴瘤(Non-Hodgkinlymphoma,NHL)。分析比较30例正常人的外周血淋巴细胞亚群与实验组的差异,并对64例恶性血液病患者中连续动态监测的21例急性白血病患者外周血淋巴细胞亚群结果变化与预后关系进行分析。结果: 不同成人恶性血液病患者年龄分组淋巴细胞亚群变化无明显差异;恶性血液病患者中CD3 +CD8 + T淋巴细胞百分比、Treg细胞百分比均增加;CD16 +/CD56 +NK细胞百分比及CD4 +/CD8 +比值均下降;CD3 +T淋巴细胞数量、CD3 +CD4 +淋巴细胞数、CD3 +CD8 +淋巴细胞数量、CD3 -CD19 +淋巴细胞数量、CD16 +/CD56 +NK淋巴细胞数量及CD4 +/CD8 +比值均减少;急性白血病及恶性淋巴瘤患者外周血淋巴细胞亚群与正常对照组比较存在一定的差异;急性白血病未缓解组的Treg细胞比例明显高于急性白血病首疗程缓解组及对照组;急性白血病复发组Treg细胞比例明显高于急性白血病持续缓解组以及对照组;对21例急性白血病患者动态监测的淋巴细胞亚群发现,化疗缓解的患者Treg在化疗过程中逐渐下降,至第3~6个疗程逐渐接近正常对照,化疗未缓解的患者Treg细胞在化疗过程中逐渐上升或持续大于10%,明显高于完全缓解组,复发患者Treg在化疗过程中先下降后明显上升。 结论: 恶性血液病患者免疫功能显著低于健康人,且伴随免疫功能紊乱,且不同疾病类型、不同的疾病状态免疫紊乱的程度不一,Treg细胞比例可以用来预测急性白血病患者疗效及复发,可以为患者的临床治疗方案及用药强度提供指导依据。 相似文献
87.
Adoptive cell therapy of tumor-infiltrating lymphocytes has shown promise for treatment of refractory melanoma and other solid malignancies; however, challenges to manufacturing have limited its widespread use. Traditional manufacturing efforts were lengthy, cumbersome and used open culture systems. We describe changes in testing and manufacturing that decreased the process cycle time, enhanced the robustness of critical quality attribute testing and facilitated a functionally closed system. These changes have enabled export of the manufacturing process to support multi-center clinical trials. 相似文献
88.
《Molecular & cellular proteomics : MCP》2019,18(2):245-262
Highlights
- •AP-DIA/SWATH analysis to identify TCTP-interacting proteins in NF1 tumor cells.
- •A highly specific TCTP–EF1A2 interaction but rather than TCTP–EF1A1 interaction.
- •TCTP–EF1A2 interaction mediating formation of EF1A2-elogation factor complex.
- •TCTP–EF1A2 dependent translation machinery regulating NF1 tumor cell growth.
89.
Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma
Vaishnavi Nathan Peter A. Johansson Jane M. Palmer Madeleine Howlie Hayley R. Hamilton Karin Wadt Gran Jnsson Kelly M. Brooks Antonia L. Pritchard Nicholas K. Hayward 《Pigment cell & melanoma research》2019,32(6):854-863
Approximately 1%–2% of cutaneous melanoma (CM) is classified as strongly familial. We sought to investigate unexplained CM predisposition in families negative for the known susceptibility genes using next‐generation sequencing of affected individuals. Segregation of germline variants of interest within families was assessed by Sanger sequencing. Several heterozygous variants in oculocutaneous albinism (OCA) genes: TYR, OCA2, TYRP1 and SLC45A2, were present in our CM cohort. OCA is a group of autosomal recessive genetic disorders, resulting in pigmentation defects of the eyes, hair and skin. Missense variants classified as pathogenic for OCA were present in multiple families and some fully segregated with CM. The functionally compromised TYR p.T373K variant was present in three unrelated families. In OCA2, known pathogenic variants: p.V443I and p.N489D, were present in three families and one family, respectively. We identified a likely pathogenic SLC45A2 frameshift variant that fully segregated with CM in a family of four cases. Another four‐case family harboured cosegregating variants (p.A24T and p.R153C) of uncertain functional significance in TYRP1. We conclude that rare, heterozygous variants in OCA genes confer moderate risk for CM. 相似文献
90.
Zeynep Eroglu Sheri L. Holmen Qing Chen Nikhil I. Khushalani Ravi Amaravadi Reena Thomas Kamran A. Ahmed Hussein Tawbi Sunandana Chandra Joseph Markowitz Inna Smalley James K. C. Liu Yian Ann Chen Yana G. Najjar Florian A. Karreth Daniel Abate‐Daga Isabella C. Glitza Jeffrey A. Sosman Vernon K. Sondak Marcus Bosenberg Meenhard Herlyn Michael B. Atkins Harriet Kluger Kim Margolin Peter A. Forsyth Michael A. Davies Keiran S. M. Smalley 《Pigment cell & melanoma research》2019,32(3):458-469
In February 2018, the Melanoma Research Foundation and the Moffitt Cancer Center hosted the Second Summit on Melanoma Central Nervous System (CNS) Metastases in Tampa, Florida. In this white paper, we outline the current status of basic science, translational, and clinical research into melanoma brain metastasis development and therapeutic management. We further outline the important challenges that remain for the field and the critical barriers that need to be overcome for continued progress to be made in this clinically difficult area. 相似文献